These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
501 related items for PubMed ID: 30603887
1. Same day comparison of PET/CT and PET/MR in patients with cardiac sarcoidosis. Wisenberg G, Thiessen JD, Pavlovsky W, Butler J, Wilk B, Prato FS. J Nucl Cardiol; 2020 Dec; 27(6):2118-2129. PubMed ID: 30603887 [Abstract] [Full Text] [Related]
2. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis. Dweck MR, Abgral R, Trivieri MG, Robson PM, Karakatsanis N, Mani V, Palmisano A, Miller MA, Lala A, Chang HL, Sanz J, Contreras J, Narula J, Fuster V, Padilla M, Fayad ZA, Kovacic JC. JACC Cardiovasc Imaging; 2018 Jan; 11(1):94-107. PubMed ID: 28624396 [Abstract] [Full Text] [Related]
3. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. Okumura W, Iwasaki T, Toyama T, Iso T, Arai M, Oriuchi N, Endo K, Yokoyama T, Suzuki T, Kurabayashi M. J Nucl Med; 2004 Dec; 45(12):1989-98. PubMed ID: 15585472 [Abstract] [Full Text] [Related]
4. Efficacy of myocardial washout of 99mTc-MIBI/Tetrofosmin for the evaluation of inflammation in patients with cardiac sarcoidosis: comparison with 18F-fluorodeoxyglucose positron emission tomography findings. Suzuki M, Izawa Y, Fujita H, Miwa K, Takahashi Y, Toh H, Toba T, Fujiwara S, Hashimura H, Kono AK, Hirata KI. Ann Nucl Med; 2022 Jun; 36(6):544-552. PubMed ID: 35303274 [Abstract] [Full Text] [Related]
16. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. Blankstein R, Osborne M, Naya M, Waller A, Kim CK, Murthy VL, Kazemian P, Kwong RY, Tokuda M, Skali H, Padera R, Hainer J, Stevenson WG, Dorbala S, Di Carli MF. J Am Coll Cardiol; 2014 Feb 04; 63(4):329-36. PubMed ID: 24140661 [Abstract] [Full Text] [Related]
17. The usefulness of delayed enhancement magnetic resonance imaging for diagnosis and evaluation of cardiac function in patients with cardiac sarcoidosis. Matoh F, Satoh H, Shiraki K, Odagiri K, Saitoh T, Urushida T, Katoh H, Takehara Y, Sakahara H, Hayashi H. J Cardiol; 2008 Jun 04; 51(3):179-88. PubMed ID: 18522793 [Abstract] [Full Text] [Related]
18. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease. Asabella AN, Cimmino A, Altini C, Notaristefano A, Rubini G. Hell J Nucl Med; 2011 Jun 04; 14(3):311-2. PubMed ID: 22087457 [Abstract] [Full Text] [Related]
19. More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT. Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. Hell J Nucl Med; 2019 Jun 04; 22(1):6-9. PubMed ID: 30843003 [Abstract] [Full Text] [Related]
20. Diagnostic performance of F-18 FDG PET for detection of cardiac sarcoidosis; A systematic review and meta-analysis. Kim SJ, Pak K, Kim K. J Nucl Cardiol; 2020 Dec 04; 27(6):2103-2115. PubMed ID: 30603894 [Abstract] [Full Text] [Related] Page: [Next] [New Search]